OrthoPediatrics Achieves Milestone in Pediatric Implant Study
OrthoPediatrics Achieves Milestone in Pediatric Implant Study
OrthoPediatrics Corp. is excited to announce a major development in its Global POISE Study, which is focused on pediatric orthopedic implants. The company, recognized in the medical community as a leader in this specialized field, has successfully reached an impressive milestone: over 600 orthopedic implants are now being tracked across more than 300 pediatric patients.
Global POISE Study Overview
The Global POISE (Pediatric Orthopedic Implant Safety and Efficacy) Study represents a comprehensive multi-center initiative aimed at thoroughly assessing the safety and effectiveness of various orthopedic implant devices designed specifically for children. This extensive research effort began in 2023 and spans an international network of 13 active sites, currently gathering data from countries such as Canada, Australia, New Zealand, and South Africa, alongside the United States.
Study Goals and Importance
This study is pivotal in verifying the long-term survival and identifying any potential device-related adverse events associated with the implants. The insights gained will not only help refine product offerings but will also enhance the overall safety and effectiveness of pediatric orthopedic care tailored to the unique needs of children.
Insights from the Research Team
Ray Garrison, the Senior Vice President of Quality, Clinical and Regulatory Affairs at OrthoPediatrics, expressed enthusiasm about the study's progress. He noted, "We are thrilled to see the Global POISE Study reach this significant milestone. Our collaboration with the research team at BC Children’s Hospital is having a meaningful impact. As the study expands, we look forward to the valuable insights that will ultimately enhance orthopedic outcomes for children worldwide. OrthoPediatrics is dedicated to continuing innovation in pediatric orthopedic care."
Commitment to Pediatric Orthopedic Care
OrthoPediatrics remains committed to developing innovative orthopedic solutions that specifically address the medical challenges faced by children with orthopedic conditions. With 17 different implant types being studied, the company continues to enroll additional patients to ensure a comprehensive understanding of the implants' safety and long-term effectiveness.
Expert Leadership in Pediatric Research
The Global POISE study is spearheaded by prominent orthopedic surgeons, Dr. Anthony Cooper and Dr. Kishore Mulpuri, at BC Children’s Hospital. This institution, located in Vancouver, is renowned for its pioneering work in pediatric healthcare, especially in the research and treatment of orthopedic conditions among children.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is dedicated exclusively to the advancement of the pediatric orthopedic market. The company has developed a comprehensive range of over 80 specialized products in trauma and deformity, scoliosis, sports medicine, and other orthopedic procedures. OrthoPediatrics operates with a global sales organization that focuses solely on pediatric orthopedic solutions, distributing its products in over 70 countries worldwide.
Conclusion and Future Directions
As the Global POISE Study develops, OrthoPediatrics is excited about the future possibilities that lie ahead in pediatric orthopedic care. It emphasizes continuing to collaborate with healthcare professionals around the globe to improve the lives of children facing orthopedic challenges. OrthoPediatrics is committed to pushing the boundaries of innovation to ensure that young patients receive the best possible care.
Frequently Asked Questions
What is the Global POISE Study?
The Global POISE Study is a significant clinical research effort aimed at assessing the safety and efficacy of orthopedic implants in pediatric patients.
How many patients are involved in the Global POISE Study?
The study currently observes over 300 pediatric patients who have received more than 600 orthopedic implants.
Who are the principal investigators of the study?
Dr. Anthony Cooper and Dr. Kishore Mulpuri from BC Children’s Hospital lead the research efforts of the Global POISE Study.
What types of products does OrthoPediatrics offer?
OrthoPediatrics markets over 80 products, primarily targeting pediatric trauma, scoliosis, and sports medicine, among other orthopedic needs.
What is OrthoPediatrics' mission?
OrthoPediatrics is committed to advancing pediatric orthopedic care through innovative solutions that meet the special needs of young patients.
About The Author
Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.